Malignant Intracranial Neoplasm — Trials

Malignant Intracranial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

637 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 192
Recruiting: 110
Ph III recruiting: 4
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (100)

clinicaltrialsPublishedShowing 101–103 of 103 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00185861	Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma	completed	Phase 1	12	Stanford UniversityOTHER	1	Apr 9, 2009	clinicaltrials
NCT00553748	Phase I, Open Label, Single Center Safety Study of [F-18]FLT	completed	Phase 1	11	Siemens Molecular ImagingINDUSTRY	1	Jul 3, 2008	clinicaltrials